Using defined inclusion criteria to establish baseline cognitive deficits in CIAS clinical trials

Cognitive deficits are a core feature of schizophrenia but not all patients function below the normal range expected in the absence of illness.

The aim of this research was to establish the extent to which subjects are prescreened for cognitive deficits in schizophrenia clinical trials using cognition as an endpoint.

Download

First name *

Last name *

Organisation / Institution *

Email *

Telephone *

Country *

Area of interest *

Where did you hear about us?

We would like to keep you informed with the latest news, data and innovations from the neuroscience and clinical trial community. We'll always treat your contact information with great care and will never allow other companies to access your information for marketing purposes.

Please let us know if you would like us to contact you or not by selecting one of the options below.

Yes please, I would like to stay up to date with the neuroscience research and clinical trial communities.

No thanks, I don't want to hear about the latest news, scientific data and technology innovations.

This field is intended to catch out spammers - please leave it blank.

Using defined inclusion criteria to establish baseline cognitive deficits in CIAS clinical trials

Using defined inclusion criteria to establish baseline cognitive deficits in CIAS clinical trials

Download

Download form

Share this